PT - JOURNAL ARTICLE AU - Suckiel, Sabrina A. AU - Odgis, Jaqueline A. AU - Gallagher, Katie M. AU - Rodriguez, Jessica E. AU - Watnick, Dana AU - Bertier, Gabrielle AU - Sebastin, Monisha AU - Yelton, Nicole AU - Maria, Estefany AU - Lopez, Jessenia AU - Ramos, Michelle AU - Kelly, Nicole AU - Teitelman, Nehama AU - Beren, Faygel AU - Kaszemacher, Tom AU - Davis, Kojo AU - Laguerre, Irma AU - Richardson, Lynne D. AU - Diaz, George A. AU - Pearson, Nathaniel M. AU - Ellis, Stephen B. AU - Stolte, Christian AU - Robinson, Mimsie AU - Kovatch, Patricia AU - Horowitz, Carol R. AU - Gelb, Bruce D. AU - Greally, John M. AU - Bauman, Laurie J. AU - Zinberg, Randi E. AU - Abul-Husn, Noura AU - Wasserstein, Melissa P. AU - Kenny, Eimear E. TI - GUÍA: a digital platform to facilitate result disclosure in genetic counseling AID - 10.1101/2020.09.14.20194191 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.14.20194191 4099 - http://medrxiv.org/content/early/2020/09/18/2020.09.14.20194191.short 4100 - http://medrxiv.org/content/early/2020/09/18/2020.09.14.20194191.full AB - Purpose Use of genomic sequencing is increasing at a pace that requires technological solutions to effectively meet the needs of a growing patient population. We developed GUÍA, a web-based application, to enhance the delivery of genomic results and related clinical information to patients and families.Methods GUÍA development occurred in 5 phases: formative research, content development, user interface design, stakeholder/community member input, and web application development. Development was informed by qualitative research involving parents (N=22) whose children underwent genomic testing. Participants enrolled in the NYCKidSeq pilot study (N=18) completed structured feedback interviews post-result disclosure using GUÍA. Genetic specialists, researchers, patients, and community stakeholders provided their perspectives on GUÍA’s design to ensure technical, cultural, and literacy appropriateness.Results NYCKidSeq participants responded positively to the use of GUÍA to deliver their children’s results. All participants (N=10) with previous experience with genetic testing felt GUÍA improved result disclosure, and 17 (94%) participants said the content was clear.Conclusions GUÍA communicates complex genomic information in an understandable and personalized manner. Initial piloting demonstrated GUÍA’s utility for families enrolled NYCKidSeq pilot study. Findings from the NYCKidSeq clinical trial will provide insight into GUÍA’s effectiveness in communicating results among diverse, multilingual populations.Competing Interest StatementDr. Kenny has received speaker honorariums from Regeneron and Illumina. Dr. Abul-Husn was previously employed by Regeneron Pharmaceuticals and has received a speaker honorarium from Genentech. Ms. Zinberg has received consulting fees from Sema4. All other authors declare they have no competing interest.Funding StatementResearch reported in this publication was supported by the National Human Genome Research Institute and National Institute for Minority Heath and Health Disparities of the National Institutes of Health under Award Number 1U01HG0096108.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Boards (IRB) of Icahn School of Medicine at Mount Sinai and Albert Einstein College of Medicine approved the Formative Study and the NYCKidSeq Study. Informed consent was obtained from all participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available from the corresponding author upon request.